ý

Expert Directory - Gynecologic Cancer

Showing results 1 – 3 of 3

Teresa Diaz-Montes, MD, MPH, FACOG

Associate Director, The Lya Segall Ovarian Cancer

Mercy Medical Center

Fertility, Gynecologic Cancer, Gynecologic Oncology, Gynecologic Surgery, Gynecology

Teresa P. Diaz-Montes, M.D., MPH, FACOG, serves as the Associate Director of The Lya Segall Ovarian Cancer Institute. She also is a noted expert and gynecologic oncologist with The Gynecologic Oncology Center at Mercy, a leading Center in Baltimore for the treatment of cancers of the female reproductive tract. Dr. Teresa Diaz-Montes provides diagnosis and treatment for gynecologic cancers including ovarian cancer, cervical cancer, uterine cancer, vaginal cancer, and vulvar cancer. Board Certified in Gynecologic Oncology, Dr. Teresa Diaz-Montes provides treatment for a diverse range of gynecologic cancers. Her primary clinical interests include ovarian cancer treatments, minimally invasive gynecologic surgery, including robotic surgery, and patient safety and quality. Additional areas of interest include cervical cancer, fallopian tube cancer, fertility-sparing surgery and uterine, vaginal and vulvar cancers. Bringing a friendly approach to the treatment of her patients, Dr. Diaz-Montes takes the necessary time to listen to the needs of her patients and address their concerns. As a recipient of the Patient's Choice award, her approachable, caring bedside manner has been formally recognized by her patients. Dr. Teresa Diaz-Montes is known for her knowledge and dedication to finding advanced treatments for gynecologic cancers. Her expert opinion is often sought by media outlets and she has been featured in notable publications such as The Wall Street Journal and The New York Times. She was also featured by The Sun Magazine as "One of 50 Women to Watch" for her dedication to innovative treatments for ovarian cancer. Dr. Diaz-Montes has extensive experience in research and resident teaching activities. She has conducted various clinical trials to advance the care of gynecologic cancers, particularly ovarian cancer. She and colleagues in The Institute for Cancer Care at Mercy are conducting the first clinical study in the United States regarding the treatment of ovarian cancer with hyperthermic intraperitoneal chemotherapy, also known as HIPEC. Dr. Diaz-Montes, an author and international lecturer, has numerous clinical publications related to women’s cancer treatment to her credit.
Awards and Honors
Top Doctor in Gynecologic Oncology, Baltimore magazine
Top Doctor in Gynecologic Oncology, Castle Connolly Medical Ltd.

Eleonora Teplinsky, MD

Head, Breast and Gynecological Medical Oncology, Valley-Mount Sinai Comprehensive Cancer Careck Breast Cancer Experience

Living Beyond Breast Cancer

Biomarker, Breast Cancer, Gynecologic Cancer, Oncology, Woman's Health


Her clinical and research interests focus on young women with breast cancer, survivorship, exercise oncology, and the use of social media in oncology. She is passionate about oncology education and advocacy on social media and is the host of the INTERLUDE Podcast, where she shares the stories and experiences of those who have been affected by cancer. The podcast provides support, inspiration, encouragement, hope, and strength to others who are going through similar experiences.

You can also follow Dr. Teplinsky's work and advocacy on and .

Ramez Eskander, MD

Director, clinical trials office for oncology

UC San Diego Health

Clinical Trials, Diagnostics, Gynecologic Cancer, Minimally Invasive Surgery, Ovarian Cancer, Robotic Surgery, Uterine Cancer, Vaginal Cancer

, is a gynecologic oncologist who specializes in the surgical management of female reproductive system cancers, including ovarian, uterine, cervical, vulvar and vaginal cancer. His expertise includes diagnostic and therapeutic procedures, including minimally invasive surgery, chemotherapy and novel drugs.

Eskander is also experienced in clinical trial development and aims to provide individuals with access to innovative medicines during their treatment. He is a member of  and the clinical trials office director for oncology.

As an assistant professor in the Department of Obstetrics, Gynecology, and Reproductive Sciences at University of California San Diego, Eskander instructs medical students, residents and fellows. His research focuses on immunotherapy, targeted therapies for treating clear cell and endometrioid ovarian cancer, quality of life in cancer patients, and end-of-life care.

Eskander speaks Arabic and Spanish fluently.

Showing results 1 – 3 of 3

close
0.12499